文献速递心胸血管麻醉气道管理

持续气道正压预防心脏术后再插管:多中心随机临床试验

Continuous positive airway pressure to prevent reintubation in patients recovering from cardiac surgery: A multicentre randomised clinical trial.
PubMed 文献 · Eur J Anaesthesiol · 2025-06-27

该多中心开放标签随机试验在意大利10所大学附属医院纳入体外循环心脏术后拔管1小时内PaO2/FiO2≤200的成人患者,评估CPAP能否减少再插管。因资金限制提前终止导致样本量不足。结果显示CPAP未显著降低28天再插管率,但显著减少肺不张和48小时再插管,并改善氧合。

要点

  • 心脏术后低氧患者CPAP未显著降低28天再插管率(8.3% vs 10.8%,P=0.3908)。
  • CPAP显著降低肺不张发生率(14.2% vs 24.1%,P=0.0110)。
  • CPAP组48小时再插管率显著更低(2.94% vs 7.39%,P=0.0425),氧合显著改善。

核心结论

  • 与文丘里面罩吸氧相比,CPAP未显著降低心脏术后低氧患者28天再插管率,但显著减少肺不张和48小时再插管并改善氧合。

研究设计与样本

  • 多中心、开放标签、随机临床试验,因资金限制提前终止导致样本量不足。
  • 在意大利10所大学附属医院纳入体外循环心脏术后拔管1小时内PaO2/FiO2≤200的成人患者。
  • 排除严重COPD、既往机械通气及未同意者。

主要发现

  • 再插管发生率对照组10.8%(95%CI 6.52–15.15),治疗组8.3%(95%CI 4.51–12.16),P=0.3908。
  • 肺不张发生率对照组24.1%(95%CI 18.20–30.07),治疗组14.2%(95%CI 9.38–19.05),P=0.0110。
  • 48小时再插管率CPAP组2.94%(95%CI 0.60–5.28),对照组7.39%(95%CI 3.76–11.02),P=0.0425。
  • 肺炎、脓毒症和死亡率无显著差异;CPAP显著改善氧合(P<0.0001)。

关键数值与推荐

  • 主要终点为术后28天内再插管。
  • 次要终点包括肺不张、肺炎、脓毒症、死亡率和氧合。

临床怎么用

  • 对心脏术后拔管后低氧(PaO2/FiO2≤200)患者,CPAP可考虑用于减少肺不张和早期再插管并改善氧合。
  • CPAP对28天再插管率的影响未达统计学显著,需结合个体情况决定。

局限性

  • 研究因资金限制提前终止,样本量不足(underpowered)。
  • 开放标签设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pulmonary complications, including atelectasis and reintubation, are common after cardiac surgery and are associated with increased morbidity and mortality. Postoperative continuous positive airway pressure (CPAP) may reduce these risks, but its effectiveness remains uncertain. OBJECTIVES: To assess whether CPAP reduces the need for reintubation in hypoxaemic patients after cardiac surgery, and to evaluate its effect on other postoperative pulmonary complications. DESIGN: Multicentre, open-label, randomised clinical trial. The study was prematurely terminated due to funding constraints, leading to an underpowered sample. SETTING: Ten university-affiliated hospitals across Italy. PATIENTS: Adults undergoing cardiac surgery with cardiopulmonary bypass who developed a Pa O 2 /FiO 2 ratio 200 or less within 1 h of extubation. Exclusion criteria included severe COPD, previous mechanical ventilation and lack of consent. MAIN OUTCOME MEASURES: The primary endpoint was reintubation within 28 days of surgery. Secondary endpoints included atelectasis, pneumonia, sepsis, mortality and oxygenation. RESULTS: The incidence of reintubation was 10.8% (95% confidence interval [CI], 6.52 to 15.15) in the control group and 8.3% (95% CI, 4.51 to 12.16) in the treatment group ( P = 0.3908). In contrast, the occurrence of atelectasis was significantly higher in the control group at 24.1% (95% CI, 18.20 to 30.07) compared with 14.2% (95% CI, 9.38 to 19.05) in the treatment group ( P = 0.0110). At 48 h, the incidence of reintubation was significantly lower in the CPAP group 2.94% (95% CI, 0.60 to 5.28) compared with the control group, 7.39% (95% CI, 3.76 to 11.02), P = 0.0425. No significant differences in pneumonia, sepsis or mortality were observed. CPAP significantly improved oxygenation ( P < 0.0001). CONCLUSION: CPAP did not significantly reduce 28-day reintubation rates compared with oxygen therapy via Venturi mask. However, CPAP was associated with a significant reduction in atelectasis and early reintubation at 48 h. Further research is warranted to confirm these findings and compare CPAP with other noninvasive support strategies. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01726140.

来源:Eur J Anaesthesiol,查看原文。版权归原作者所有。

引用

  1. Pasero D, Costamagna A, Filippini C, et al. Continuous positive airway pressure to prevent reintubation in patients recovering from cardiac surgery: A multicentre randomised clinical trial. Eur J Anaesthesiol. 2025. PMID: 40574561. doi:10.1097/EJA.0000000000002229

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。